Violations and sanctions
FIB’s anti-doping regulations identify 11 different anti-doping rule violations (ADRV).
- Presence of a prohibited substance.
- Use or attempted use, of a prohibited substance
- Evading, refusing or failing to submit to sample collection
- Whereabouts failures
- Tampering or attempted tampering with any part of the doping control
- Possession of a prohibited substance or method
- Trafficking or attempted trafficking in any prohibited substance or method
- Administration or attempted administration of a prohibited substance or method
- Complicity
- Prohibited Association
- Acts to discourage or retaliate against reporting to authorities
The rules and sanctions not only apply to athletes, but also to coaches, doctors or other kind of athlete support persons – everyone involved in sport.
Any validated violation will be sanctioned. Under the WADC, sanctions are applied consistently, in all sports and all over the world. Depending on the violation and the circumstances involved, sanctions may range from a formal warning to a lifetime ban. As an example, a “normal” case – where e.g. anabolic steroids, beta-2 agonists or diuretics have been found – will result in the four year period of ineligibility.
During the ineligibility period the sanctioned person will be prohibited to participate, in any capacity, in all activities (competitions, training etc.) organized by a National Federation, Club or any other Organization.
Apart from individual sanctions, there could also be implications for his/her team, including loss of matches and disqualification from an event.
Lern more:
WORLD ANTI-DOPING CODE (WADC)
FIB ANTI-DOPING REGULATIONS (Article 10-12)
CURRENT SANCTIONS
In accordance with FIB Anti-Doping Regulations, and in line with World Anti-Doping Code, any athlete or other person who have committed an Anti-Doping Rule Violation (ADRV) will be publicly disclosed by publishing on this website.
Name (M/F) | Nation | From | Until | Event type* | Substance/ADRV |
Petr GRIBANOV (M) | KAZ | 22 March 2023 | 22 March 2026 | OOC | Indapamide and Meldonium/ Art. 2.1 FIB ADR |
Almaz MIRGAZOV (M) | RUS | 21 Sept 2023 | 21 March 2026 | IC | SARMS enobosarm (ostarine)/Art. 2.1 FIB ADR |
*IC: In-Competition; OOC: Out-of-Competition